ANI Pharmaceuticals (ANIP) Is Up 7.0% After Raising 2026 Revenue Outlook and Expanding Rare Disease Team [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
strong contributions from its rare disease portfolio, particularly Purified Cortrophin Gel. The company also outlined plans to hire roughly 90 additional rare disease specialists to expand Cortrophin Gel into new treatment settings, signaling a deeper commitment to this therapy as a core growth engine. We'll now examine how ANI Pharmaceuticals' ambitious 2026 revenue outlook and rare disease team expansion might reshape its investment narrative. Rare earth metals are the new gold rush. Find out which 38 stocks are leading the charge To own ANI Pharmaceuticals, you need to believe the company can keep scaling its rare disease portfolio while managing reliance on Purified Cortrophin Gel. The new 2026 revenue guidance and planned 90-person rare disease expansion reinforce Cortrophin Gel as the key near term catalyst, but they also sharpen the main risk around higher operating expenses and payer pushback if ACTH spending draws more scrutiny. The 2026 revenue outlook of US$1.06 b
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- ANI Pharmaceuticals (ANIP) Stock Trades Down, Here Is Why [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals: Strong 2025 Finish And Bullish 2026 Guidance [Seeking Alpha]Seeking Alpha
- Stocks making big moves yesterday: OneMain, Nextpower, ANI Pharmaceuticals, Akamai Technologies, and Lemonade [Yahoo! Finance]Yahoo! Finance
- Why ANI Pharmaceuticals (ANIP) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities [Yahoo! Finance]Yahoo! Finance
ANIP
Earnings
- 11/7/25 - Beat
ANIP
Sec Filings
- 1/14/26 - Form 4
- 1/12/26 - Form 8-K
- 12/19/25 - Form 4
- ANIP's page on the SEC website